NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 888.75
+5.50 (0.62%)
At close: Jun 19, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 158.39 billion as of June 22, 2026. Its market cap has increased by 0.10% in one year.
Market Cap
158.39B
Enterprise Value
144.23B
Revenue
40.78B
Ranking
n/a
PE Ratio
11.17
Stock Price
888.75
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 158.39B, an increase of 36,786.61%. That is a compound annual growth rate of 24.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 159.23B | -1.56% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |
| Granules India | 194.73B |
| Caplin Point Laboratories | 190.50B |
| Jubilant Pharmova | 152.96B |
| CORONA Remedies | 114.28B |